Related Party Transactions (Details) - USD ($) $ in Thousands |
Sep. 30, 2020 |
Jun. 12, 2020 |
---|---|---|
Maximum credit facility amount | $ 2,000 | |
Credit facility amount | $ 0 | |
Aggregate interest percentage | 7.00% | |
Invagen Pharmaceuticals Inc [Member] | ||
Credit facility amount | 1,200 | |
Fortress [Member] | ||
Credit facility amount | $ 800 |
X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|